Sofinnova, three seed investments in biotechnology for 6 million euros

Sofinnova Partners has made three new investments with Sofinnova Telethon, the start-up fund dedicated to investments for rare genetic diseases. The three new seed investments, which together amount to 6 million euros, go to startups AAVantgarde Bio, Alia Therapeutics, and Borea Therapeutics. «These investments mark an important step in our mission to support the excellent scientific research of Italian universities and research centers. They emphasize …